The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts

Journal of Medical Virology

Volumn 60, Issue 3, 2000, Pages 313-323

  Cinatl Jr , Jindrich ^a,c   Kotchetkov, Ruslan ^a   Weimer, Eveline ^a   Blaheta, Roman A ^a,b   Scholz, Martin ^a   Vogel, Jens Uwe ^a,b   Gümbel, Herman O ^a   Doerr, Hans Wilhelm ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Abt Padiatrische Hamatologie O   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Antisense oligonucleotides; Antiviral drugs; Chemoattractants; Human cytomegaloviruses; Immunopathology

Indexed keywords

CIDOFOVIR; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; FIBROBLAST; HUMAN; HUMAN CELL; VIRUS CELL INTERACTION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOMEGALOVIRUS INFECTIONS; CYTOSINE; FIBROBLASTS; FOSCARNET; GANCICLOVIR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; NEUTROPHILS; OLIGONUCLEOTIDES, ANTISENSE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIONUCLEOTIDES; UP-REGULATION;

EID: 0033972315     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200003)60:3<313::AID-JMV10>3.0.CO;2-K     Document Type: Article

References (53)

1. Anderson KP, Fox MC, Driver VB, Martin MJ, Azad RF. 1996. Inhibition of human cytomegalovirus immediate early gene expression by an antisense oligonucleotide complementary to immediate early RNA. Antimicrob Agents Chemother 40:2004-2011.
2. Anisowicz A, Messineo M, Lee SW, Sager R. 1991. An NF-κB like transcription factor mediates IL-1/TNF-alpha induction of GRO in human fibroblasts. J Immunol 147:520-527.
3. Azad RF, Driver VB, Tanaka K, Crooke RM, Anderson KP. 1993. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region. Antimicrob Agents Chemother 37:1945-1954.
4. Blaheta R, Hailer N, Harder S, Scholz M, Bereiter-Hahn J, Markus BH. 1994. Up- and down-regulation of lymphocyte infiltration through allogeneic endothelial cell monolayers. Tx Med 6:53-59.
5. Boldogh I, Fons MP, Albrecht T. 1993. Increase levels of sequence specific DNA-binding proteins in human cytomegalovirus-infected cells. Biochem Biophys Res Commun 197:1505-1510.
6. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD. 1994. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54:5036-5040.
7. Burns L, Pooley JC, Walsh DJ, Vercelloti GM, Weber ML, Kovacs A. 1999. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation 67:137-144.
8. Capobianchi MR, Barresi C, Borghi P, Gessani S, Fantuzzi L, Ameglio F, Belardelli F, Papadia S, Dianzani F. 1997. Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8. J Virol 71:1591-1597.
9. Cinatl J Jr., Cinatl J, Rabenau H, Gümbel HO, Chenot J-F, Scholz M, Encke A, Doerr HW. 1995. In vitro inhibition of human cytomegalovirus replication in endothelial cells by ascorbic acid 2-phosphate. Antiviral Res 27:405-417.
10. Cinatl J Jr., Kotchetkov R, Scholz M, Cinatl J, Vogel J-U, Hernáiz-Driever P, Doerr HW. 1999. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol 155:285-292.
11. Craigen JL, Grundy JE. 1996. Cytomegalovirus induced upregulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation 62:1102-1108.
12. Craigen JL, Yong KL, Jordan JN, MacCormac LP, Westwick J, Akbar AN, Grundy JE. 1997. Human cytomegalovirus infection upregulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 92:138-145.
13. Dezube BJ, Pardee AB, Beckett LA, Ahlers CM, Ecto L, Allen-Ryan J, Anisowicz A, Sager R, Crumpacker CS. 1992. Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO. J Acquired Immune Defic Syndr 5:1099-1104.
14. Emanuel D, Cunningham I, Jules-Elysee K, Brockstein JA, Kerman NA, Laver J, Stover D, White DA, Fels A, Polsky B, Castro-Malaspina H, Peppard JR, Bartus P, Hammerling U, O'Reilly RR. 1988. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 109: 777-782.
15. Fishman JA, Rubin RH. 1998. Infection in organ-transplant recipients. N Engl J Med 338:1741-1751.
16. Grundy JE, Shanley JD, Griffiths PD. 1987. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet 2:996-999.
17. Grundy JE, Downes KL. 1993. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology 78:405-412.
18. Grundy JE, Pahal GS, Akbar AN. 1993. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody. Immunology 78:413-420.
19. Grundy JE. 1998. Current antiviral therapy fails to prevent the proinflammatory effects of cytomegalovirus infection, whilst rendering infected cells relatively resistant to immune attack. In: Scholz M, Rabenau HF, Doerr HW, Cinatl J. Jr., editors. CMV-Related immunopathology, monographs in virology, vol. 21. Basel: Karger, p 67-89.
20. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. 1998. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J Infect Dis 177:1465-1467.
21. Hagemeier C, Caswell R, Hayhust G, Sinclair JH, Kouzarides T. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J 13:2897-2903.
22. Harada A, Mukaida N, Matsushima K. 1996. Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases. Mol Med Today 2:482-489.
23. Holland GN, Pepose JS, Pettit DH. 1983. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology 90:859-873.
24. Humar A, Louis PS, Mazzulli T, McGeer A, Lipton J, Messner H, MacDonald KS. 1999. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. J Infect Dis 179:484-488.
25. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R. 1997. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1443-1445.
26. Karavellas MP, Plummer DJ, Macdonald C, Torriani FJ, Shufelt CL, Azen SP, Freeman WR. 1999. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients after institution of successful highly active antiretroviral therapy. J Infect Dis 179:697-700.
27. Lautenschlager I, Hockerstedt K, Jalanko H, Loginov R, Salmela K, Taskinen E, Ahonen J. 1997. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 25:190-194.
28. Michelson S, Dal Monte P, Zipeto D, Bodaghi B, Laurent L, Oberlin E, Arenzana-Seisdesos F, Virelizier J-L, Landini MP. 1997. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol 71:6495-6500.
29. Mitchell SM, Youle MS, Membrey WL, Jones CD. 1997. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 350:588-590.
30. Mocarski, S Jr. 1996. Cytomegaloviruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanosk RM, Melnick JM, Monath TP, Roizman B, Straus SE, editors. Fields virology. Philadelphia, New York: Lippincott-Raven Publishers. p 2447-2492.
31. Monick MM, Geist LJ, Stinski MF, Hunninhake GW. 1992. The immediate early genes of cytomegalovirus up-regulate expression of the cellular genes myc and fos. Am J Respir Cell Mol Biol 7:251-256.
32. Mukaida N, Shiroo M, Matsushima K. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143:1366-1371.
33. Murayama T, Kuno K, Jisaki F, Obuchi M, Sakamuro D, Furukawa T, Mukaida N, Matsushima K. 1994. Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. J Virol 68:7582-7585.
34. Murayama T, Ohara Y, Obuchi M, Khabar KSA, Higashi H, Mukaida N, Matsushima K. 1997. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line THP-1, through acting concurrently on AP-1 and NF-κB-binding sites of the interleukin-8 gene. J Virol 71:5692-5695.
35. Naesens L, Snoeck R, Andrei G, Balzarini J, Neyts J, De Clercq E. 1997. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections. Antiviral Chem Chemother 8:1-23.
36. Neyts J, Snoeck R, Balzarini J, De Clercq E. 1991. Particular characteristics of the anti-human cytomegalovirus activity of (s)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine (HPMPC) in vitro. Antiviral Res 16:41-52.
37. Pouteil Noble C, Ecochard R, Landrivon G, Donia Maged A, Tardy JC, Bosshard S, Colon S, Betuel H, Aymard M, Touraine JL. 1993. Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 55:851-857.
38. Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Krüger DH. 1995. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNF-alpha is mediated via induction of NF-κB. Virology 206:197-206.
39. Pulliam L, Moore D, West DC. 1995. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: possible role in neurotoxicity. J Neurovirol 1:219-227.
40. Scholz M, Hamann A, Blaheta RA, Auth MKH, Encke A, Markus BH. 1992. Cytomegalovirus- and interferon-related effects on human endothelial cells: cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-α. Human Immunol 35:230-238.
41. Scholz M, Blaheta RA, Cinatl J, Encke A, Doerr HW, Markus BH. 1995. Lymphocytes induce enhanced expression of HLA class I antigens on cytomegalovirus-infected syngeneic human endothelial cells. Human Immunol 44:136-144.
42. Scholz M, Vogel J-U, Blaheta R, Cinatl J Jr. 1998. Cytomegalovirus, oxidative stress and inflammation as interdependent pathomechanisms: need for novel therapeutic strategies? In: Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr, editors. CMV-related immunopathology, monographs in virology, vol. 21. Basel: Karger. p 90-105.
43. Sedmak DD, Knight DA, Vook NA, Waldman WJ. 1994. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 58:1379-1385.
44. Span AHM, Mullers W, Miltenburg AMM, Bruggeman CA. 1991. Cytomegalovirus-induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology 72:355-360.
45. St. Jeor S, Admiraud J, Bruening E, Riolo J. 1993. Induction of cytokines by human cytomegalovirus. In: Michelson S, Plotkin SA, editors. Multidisciplinary approach to understand cytomegalovirus disease. Amsterdam: Elsevier Science. p 123-126.
46. Tuder RM, Weinberg A, Panatjotoboulos N, Kalil J. 1991. Cytomegalovirus enhances PBMC binding and HLA class I expression on cultured endothelial cells. Transplant Proc 23:91.
47. van de Stolpe A, van der Saag PT. 1996. Intercellular adhesion molecule-1. J Mol Med 74:13-33.
48. Vogel J-U, Scholz M, Cinatl J Jr. 1998. Treatment of CMV diseases. Intervirology 40:357-367.
49. von Willebrand E, Pettersson E, Ahonen J, Häyry P. 1986. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42:364-367.
50. Wakita H, Nishimura K, Tokura Y, Furukawa F, Takigawa M. 1996. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma. J Invest Dermatol 107:336-3342.
51. Waldman WJ, Knight DA, Huang EH, Sedmak DD. 1995. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 171:263-272.
52. Waldman WJ, Knight DA. 1996. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol 148:105-119.
53. Yurochko AD, Hwang E-S, Rasmussen L, Keay S, Pereira L, Huang E-S. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of SP1 and NF-κB during infection. J Virol 71:5051-5059.